Affymax, Inc. (AFFY)
OTCMKTS · Delayed Price · Currency is USD
0.0016
0.00 (0.00%)
At close: Sep 25, 2026
Affymax Market Cap
Affymax has a market cap or net worth of $119.18 thousand as of September 25, 2026. Its market cap has increased by 100.00% in one year.
Market Cap
119.18K
Enterprise Value
n/a
Revenue
42.00K
Ranking
n/a
PE Ratio
0.02
Stock Price
$0.00
ChartMarket Cap Chart
Since December 15, 2006, Affymax's market cap has decreased from 484.83M to 119.18K, a decrease of -99.98%. That is a compound annual growth rate of -34.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 119.18K | 100.00% |
| Dec 31, 2025 | 59.59K | - |
| Dec 31, 2024 | 59.59K | 33.33% |
| Dec 29, 2023 | 44.69K | -85.00% |
| Dec 30, 2022 | 297.96K | -33.33% |
| Dec 31, 2021 | 446.94K | -94.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ocean Biomedical | 185.89K |
| Regen BioPharma | 167.53K |
| CNBX Pharmaceuticals | 160.58K |
| Immunotech Laboratories | 114.99K |
| Synairgen | 110.27K |
| GB Sciences | 105.88K |
| Innovation Pharmaceuticals | 105.75K |
| Sigyn Therapeutics | 88.50K |